| SEQUENT |
Sequent Scientific reported a 13.3% year-on-year rise in Q1 net profit, while its EBITDA margin contracted by 20 basis points to 11.1%. Despite the profit growth, the stock closed nearly 4% lower, reflecting market caution amid the mixed earnings update. |
| MARKSANS |
Marksans Pharma has received US FDA approval for its 20 mg Omeprazole delayed‑release tablets, targeting the $1.1 billion gastrointestinal market and boosting its US portfolio. |
| AUBANK |
AU Small Finance Bank has received the RBI’s in-principle nod to transition into a universal bank, marking a key milestone in its growth journey. |
| LICI |
Life Insurance Corporation of India (LIC) reported a 4.7% year-on-year increase in net premium income to ₹1.2 lakh crore for Q1 FY26, driven primarily by growth in renewal and single premiums. |
| BHARTIARTL |
Stock cracks over 3% with volume more than 20 times higher than its average weekly volume, |